Ruben Mesa, MD, provides his perspective on when to implement cytoreductive therapy in a patient with polycythemia vera regarding the dosing and administration of hydroxyurea.
For more resources and information regarding anticancer targeted therapies: [ Ссылка ]
![](https://i.ytimg.com/vi/IVwEcuGY-V4/maxresdefault.jpg)